Details for New Drug Application (NDA): 202736
✉ Email this page to a colleague
The generic ingredient in SKLICE is ivermectin. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
Summary for 202736
Tradename: | SKLICE |
Applicant: | Arbor Pharms Llc |
Ingredient: | ivermectin |
Patents: | 0 |
Suppliers and Packaging for NDA: 202736
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SKLICE | ivermectin | LOTION;TOPICAL | 202736 | NDA | Azurity Pharmaceuticals | 24338-185 | 24338-185-04 | 1 TUBE in 1 CARTON (24338-185-04) / 117 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | LOTION;TOPICAL | Strength | 0.5% | ||||
Approval Date: | Feb 7, 2012 | TE: | RLD: | Yes |
Expired US Patents for NDA 202736
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | 6,103,248 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription